<HTML>
<HEAD>
<TITLE> </TITLE>
</HEAD>
<BODY>
<TABLE BORDER CELLSPACING=1 BORDERCOLOR="#000080" WIDTH=713>
<TR><TD VALIGN="TOP" HEIGHT=300><P></P></TD>
</TR>
<TR><TD VALIGN="BOTTOM" HEIGHT=100><P></P></TD>
</TR>
<TR><TD VALIGN="TOP" HEIGHT=20><P></P></TD>
</TR>
<TR><TD VALIGN="TOP" HEIGHT=233><P></P></TD>
</TR>
<TR><TD VALIGN="TOP" HEIGHT=346><P></P></TD>
</TR>
<TR><TD VALIGN="TOP" HEIGHT=33><P></P></TD>
</TR>
<TR><TD VALIGN="MIDDLE" BGCOLOR="#008080" HEIGHT=66><P></P></TD>
</TR>
<TR><TD VALIGN="TOP" HEIGHT=890><P></P></TD>
</TR>
</TABLE>
<P><A NAME="filing_0"><A NAME="id_0_0"><A NAME="doc_0_1"><A NAME="id_0_1"><A NAME="id_0_2"></A></A></A></A></A></P>
<FONT SIZE=1>
</FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><FONT SIZE=1><P>&nbsp;</P>
<P>&nbsp;</P>
</FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><B><FONT SIZE=4><P ALIGN="CENTER">UNITED STATES</P>
<P ALIGN="CENTER">SECURITIES AND EXCHANGE COMMISSION</P>
</FONT><FONT SIZE=2><P ALIGN="CENTER">Washington, DC 20549</P>
</B></FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><FONT SIZE=1>
</FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><FONT SIZE=1><P>&nbsp;</P>
<P>&nbsp;</P>
</FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><B><FONT SIZE=4><P ALIGN="CENTER">FORM 8-K</P>
</B></FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><FONT SIZE=1>
</FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><FONT SIZE=1><P>&nbsp;</P>
<P>&nbsp;</P>
</FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><B><FONT SIZE=2><P ALIGN="CENTER">CURRENT REPORT</P>
<P ALIGN="CENTER">Pursuant to Section&nbsp;13 OR 15(d) of the Securities and Exchange Act of 1934</P>
</B></FONT><FONT SIZE=1>
<B><P ALIGN="CENTER">Date of Report (Date of earliest reported event): February&nbsp;14, 2008</P>
</B></FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><FONT SIZE=1>
</FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><FONT SIZE=1><P>&nbsp;</P>
<P>&nbsp;</P>
</FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><B><FONT SIZE=5><P ALIGN="CENTER">GEOPHARMA, INC.</P>
</FONT><FONT SIZE=1><P ALIGN="CENTER">(Exact name of registrant as specified in charter)</P>
</B></FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><FONT SIZE=1>
</FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><FONT SIZE=1><P>&nbsp;</P>
<P>&nbsp;</P>
</FONT><FONT SIZE=1><P>&nbsp;</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 WIDTH=719>
<TR><TD WIDTH="34%" VALIGN="MIDDLE" HEIGHT=0>
<FONT SIZE=1><P>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM" HEIGHT=0>
<FONT SIZE=1><P>&nbsp;</FONT></TD>
<TD WIDTH="32%" VALIGN="MIDDLE" HEIGHT=0>
<FONT SIZE=1><P>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM" HEIGHT=0>
<FONT SIZE=1><P>&nbsp;</FONT></TD>
<TD WIDTH="32%" VALIGN="MIDDLE" HEIGHT=0>
<FONT SIZE=1><P>&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=13>
<B><FONT SIZE=1><P ALIGN="CENTER">Florida</B></FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM" HEIGHT=13>
<FONT SIZE=1><P>&nbsp;</FONT></TD>
<TD WIDTH="32%" VALIGN="TOP" HEIGHT=13>
<B><FONT SIZE=1><P ALIGN="CENTER">001-16185</B></FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM" HEIGHT=13>
<FONT SIZE=1><P>&nbsp;</FONT></TD>
<TD WIDTH="32%" VALIGN="TOP" HEIGHT=13>
<B><FONT SIZE=1><P ALIGN="CENTER">59-2600232</B></FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<B><FONT SIZE=1><P ALIGN="CENTER">(State or other jurisdiction</P>
<P ALIGN="CENTER">of incorporation)</B></FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM" HEIGHT=24>
<FONT SIZE=1><P>&nbsp;</FONT></TD>
<TD WIDTH="32%" VALIGN="TOP" HEIGHT=24>
<B><FONT SIZE=1><P ALIGN="CENTER">(Commission File Number)</B></FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM" HEIGHT=24>
<FONT SIZE=1><P>&nbsp;</FONT></TD>
<TD WIDTH="32%" VALIGN="TOP" HEIGHT=24>
<B><FONT SIZE=1><P ALIGN="CENTER">(IRS Employer</P>
<P ALIGN="CENTER">Identification No.)</B></FONT></TD>
</TR>
</TABLE>
<FONT SIZE=1><P>&nbsp;</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 WIDTH=719>
<TR><TD WIDTH="50%" VALIGN="MIDDLE" HEIGHT=0>
<FONT SIZE=1><P>&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="BOTTOM" HEIGHT=0>
<FONT SIZE=1><P>&nbsp;</FONT></TD>
<TD WIDTH="48%" VALIGN="MIDDLE" HEIGHT=0>
<FONT SIZE=1><P>&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP" HEIGHT=13>
<B><FONT SIZE=1><P ALIGN="CENTER">6950 Bryan Dairy Road, Largo, Florida</B></FONT></TD>
<TD WIDTH="2%" VALIGN="BOTTOM" HEIGHT=13>
<FONT SIZE=1><P>&nbsp;</FONT></TD>
<TD WIDTH="48%" VALIGN="TOP" HEIGHT=13>
<B><FONT SIZE=1><P ALIGN="CENTER">33777</B></FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP" HEIGHT=11>
<B><FONT SIZE=1><P ALIGN="CENTER">(Address of principal executive offices)</B></FONT></TD>
<TD WIDTH="2%" VALIGN="BOTTOM" HEIGHT=11>
<FONT SIZE=1><P>&nbsp;</FONT></TD>
<TD WIDTH="48%" VALIGN="TOP" HEIGHT=11>
<B><FONT SIZE=1><P ALIGN="CENTER">(Zip Code)</B></FONT></TD>
</TR>
</TABLE>
<B><FONT SIZE=1><P ALIGN="CENTER">Registrant's telephone number, including area code: (727)&nbsp;544-8866</P>
</B></FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><FONT SIZE=1>
</FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><FONT SIZE=1><P>&nbsp;</P>
<P>&nbsp;</P>
</FONT><FONT SIZE=1><P>&nbsp;</P>
<P>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</P>
</FONT><FONT SIZE=1><P>&nbsp;</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 WIDTH=591>
<TR><TD WIDTH="5%" VALIGN="TOP" HEIGHT=13><P></P></TD>
<TD WIDTH="95%" VALIGN="TOP" HEIGHT=13>
<FONT SIZE=1><P>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR>
</TABLE>
<FONT SIZE=1><P>&nbsp;</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 WIDTH=594>
<TR><TD WIDTH="5%" VALIGN="TOP" HEIGHT=13><P></P></TD>
<TD WIDTH="95%" VALIGN="TOP" HEIGHT=13>
<FONT SIZE=1><P>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR>
</TABLE>
<FONT SIZE=1><P>&nbsp;</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 WIDTH=645>
<TR><TD WIDTH="4%" VALIGN="TOP" HEIGHT=13><P></P></TD>
<TD WIDTH="96%" VALIGN="TOP" HEIGHT=13>
<FONT SIZE=1><P>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR>
</TABLE>
<FONT SIZE=1><P>&nbsp;</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 WIDTH=643>
<TR><TD WIDTH="4%" VALIGN="TOP" HEIGHT=13><P></P></TD>
<TD WIDTH="96%" VALIGN="TOP" HEIGHT=13>
<FONT SIZE=1><P>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR>
</TABLE>
<FONT SIZE=1><P>&nbsp;</P>
</FONT><FONT SIZE=1>
</FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><FONT SIZE=1><P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
</FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><FONT SIZE=1><P>&nbsp;</P>
<P><A NAME="id_0_3"><A NAME="id_0_4"></A></A></P>
</FONT><FONT SIZE=4><P>&nbsp;<A NAME="id_0_5"><A NAME="id_0_6"></A></A></P>
</FONT><FONT SIZE=1>
</FONT><B><FONT SIZE=3><P>ITEM 2.02 &#9;Results of Operations</P>
</B></FONT><FONT SIZE=1>
</FONT><FONT SIZE=3><P>&nbsp;</P>
<P>On February 14, 2008, GeoPharma, Inc. issued a press release announcing its results of operations as of and for the three and nine months ended December&nbsp;31, 2007, a copy of which is attached as Exhibit 99.1 hereto. </P>
<P>In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be &quot;filed&quot; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &quot;Exchange Act&quot;), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.</P>
<P>&nbsp;</P>
</FONT><FONT SIZE=4></FONT>
<TABLE CELLSPACING=0 BORDER=0 WIDTH=479>
<TR><TD WIDTH="14%" VALIGN="TOP" HEIGHT=13>
<B><FONT SIZE=3><P>ITEM&nbsp;9.01.</B></FONT></TD>
<TD WIDTH="86%" VALIGN="TOP" HEIGHT=13>
<B><FONT SIZE=3><P>. Financial Statements and Exhibits.</B></FONT></TD>
</TR>
</TABLE>
<FONT SIZE=1><P>&nbsp;</P>
</FONT><FONT SIZE=3><P>(c) Exhibits.&nbsp;The following documents are filed as exhibits to this report:</P>
<P>&nbsp;</P>
<P>99.1 Press release issued&nbsp;February 14, 2008</P>
<B><DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<DIR>
<P>SIGNATURES</P>
</B></DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
</DIR>
<P>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorize</P>
<P>&nbsp;</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 WIDTH=720>
<TR><TD WIDTH="50%" VALIGN="MIDDLE" HEIGHT=0>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM" HEIGHT=0>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
<TD WIDTH="49%" VALIGN="MIDDLE" HEIGHT=0>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP" HEIGHT=13>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM" HEIGHT=13>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
<TD WIDTH="49%" VALIGN="BOTTOM" HEIGHT=13>
<B><FONT SIZE=3><P>GEOPHARMA, INC.</B></FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="MIDDLE" HEIGHT=0>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
<TD WIDTH="50%" VALIGN="MIDDLE" COLSPAN=2 HEIGHT=0>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP" HEIGHT=14>
<FONT SIZE=3><P>Date: February 18, 2008</FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM" HEIGHT=14>
<FONT SIZE=3><P>&nbsp;</P>
<P>&nbsp;</FONT></TD>
<TD WIDTH="49%" VALIGN="BOTTOM" HEIGHT=14>
<FONT SIZE=3><P>/s/ Mihir K. Taneja</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP" HEIGHT=13>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM" HEIGHT=13>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
<TD WIDTH="49%" VALIGN="BOTTOM" HEIGHT=13>
<FONT SIZE=3><P>Mihir K. Taneja,</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP" HEIGHT=13>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM" HEIGHT=13>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
<TD WIDTH="49%" VALIGN="BOTTOM" HEIGHT=13>
<FONT SIZE=3><P>Chief Executive Officer</P>
<P>&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="MIDDLE" HEIGHT=0>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
<TD WIDTH="50%" VALIGN="MIDDLE" COLSPAN=2 HEIGHT=0>
<FONT SIZE=3><P>&nbsp;</P>
<P>&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP" HEIGHT=14>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM" HEIGHT=14>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
<TD WIDTH="49%" VALIGN="BOTTOM" HEIGHT=14>
<FONT SIZE=3><P>/s/ Carol Dore-Falcone</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP" HEIGHT=13>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM" HEIGHT=13>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
<TD WIDTH="49%" VALIGN="BOTTOM" HEIGHT=13>
<FONT SIZE=3><P>Carol Dore-Falcone,</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP" HEIGHT=13>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="BOTTOM" HEIGHT=13>
<FONT SIZE=3><P>&nbsp;</FONT></TD>
<TD WIDTH="49%" VALIGN="BOTTOM" HEIGHT=13>
<FONT SIZE=3><P>Vice President and Chief Financial Officer</FONT></TD>
</TR>
</TABLE>
<FONT SIZE=3><P>&nbsp;</P>
</FONT><FONT SIZE=1>
<P>&nbsp;</P>
<P>&nbsp;</P>
</FONT><FONT SIZE=3><P>&nbsp;</P>
<P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P><A NAME="id_0_9"><A NAME="id_0_10"></A></A></P>
<P ALIGN="CENTER">3</P>
<P ALIGN="CENTER"></P>
</FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><FONT SIZE=1><P>&nbsp;</P>
</FONT><FONT SIZE=1><P>&nbsp;</P>
<P>&nbsp;</P>
</FONT><FONT SIZE=1><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER"><A NAME="doc_0_2"><A NAME="page_0_2_1"></A></A></P></FONT></BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "rrd195774.htm", "secsgml_size_bytes": 11549}]
{"company-data": {"conformed-name": "GeoPharma, Inc.", "cik": "0001098315", "assigned-sic": "2834", "irs-number": "592600232", "state-of-incorporation": "FL", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-16185", "film-number": "08625342"}, "business-address": {"street1": "6950 BRYAN DAIRY RD", "city": "LARGO", "state": "FL", "zip": "33777", "phone": "7275448866"}, "mail-address": {"street1": "6950 BRYAN DAIRY RD", "city": "LARGO", "state": "FL", "zip": "33777"}, "former-company": [{"former-conformed-name": "Geopharma, Inc.", "date-changed": "20040707"}, {"former-conformed-name": "INNOVATIVE COMPANIES INC", "date-changed": "20030703"}, {"former-conformed-name": "INNOVATIVE COS INC", "date-changed": "20030627"}]}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934
Date of Report (Date of earliest reported event): February 14, 2008
GEOPHARMA, INC.
(Exact name of registrant as specified in charter)
Florida
001-16185
59-2600232
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
6950 Bryan Dairy Road, Largo, Florida
33777
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code: (727) 544-8866
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 2.02 	Results of Operations
On February 14, 2008, GeoPharma, Inc. issued a press release announcing its results of operations as of and for the three and nine months ended December 31, 2007, a copy of which is attached as Exhibit 99.1 hereto.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
ITEM 9.01.
. Financial Statements and Exhibits.
(c) Exhibits. The following documents are filed as exhibits to this report:
99.1 Press release issued February 14, 2008
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorize
GEOPHARMA, INC.
Date: February 18, 2008
/s/ Mihir K. Taneja
Mihir K. Taneja,
Chief Executive Officer
/s/ Carol Dore-Falcone
Carol Dore-Falcone,
Vice President and Chief Financial Officer
3